Cipla obtains FDA approval for generic Proventil HFACipla’s generic albuterol inhaler is the first generic to treat and prevent bronchospasm. Zydus Cadila’s generic Trilafon obtains FDA approvalThe FDA has approved Zydus Cadila’s generic Trilafon tablets in four dosage strengths. Aurobindo gets FDA OK for generic Zanaflex Aurobindo's generic Zanaflex will be available in three dosage strengths. Novartis terminates sale of Sandoz U.S. generic oral solids, dermatology portfolio to Aurobindo Sandoz will continue to operate its oral solids and dermatology business as part of the Sandoz U.S. business. Lupin launches generic Myfortic Mycophenolic acid delayed-release tablets had a market value of roughly $156 million, according to IQVIA data from February. Focus On: Upsher-Smith builds business with focus on novelty, quality As it moves into its second century in business, Upsher-Smith Labs is focusing on innovating and growing its product offerings while maintaining its high standards. Elite, Lannett launch generic Adderall XR Adderall XR, including generic versions, have a market value of approximately $1.3 billion for the 12 months ending January 2020, according to IQVIA. Zydus Cadila gets FDA OK for generic Lamictal Zydus Cadila's generic Lamictal will be available in six dosage strengths. NCPA survey: Pharmacists back access to experimental COVID-19 treatment Ninety percent of local pharmacists are reporting a shortage of hydroxychloroquine, according to an NCPA survey. Zydus gets FDA's tentative nod for generic Rytary Zydus Cadila's generic Rytary is indicated to treat Parkinson's disease. First Previous 144 145 146 147 148 Next Last